AP2S1 regulates APP degradation through late endosome–lysosome fusion in cells and APP/PS1 mice

Abstract

AP2S1 is the sigma 2 subunit of adaptor protein 2 (AP2) that is essential for endocytosis. In this study, we investigated the potential role of AP2S1 in intracellular processing of amyloid precursor protein (APP), which contributes to the pathogenesis of Alzheimer disease (AD) by generating the toxic β-amyloid peptide (Aβ). We found that knockdown or overexpression of AP2S1 decreased or increased the protein levels of APP and Aβ in cells stably expressing human full-length APP695, respectively. This effect was unrelated to endocytosis but involved lysosomal degradation.Morphological studies revealed that silencing of AP2S1 promoted the translocalization of APP from RAB9-positive late endosomes (LE) to LAMP1-positive lysosomes, which was paralleled by the enhanced LE-lysosome fusion. In support, silencing of vacuolar protein sorting-associated protein 41 (VPS41) that is implicated in LE-lyso fusion prevented AP2S1-mediated regulation of APP degradation and translocalization. In APP/PS1 mice, an animal model of AD, AAV-mediated delivery of AP2S1 shRNA in the hippocampus significantly reduced the protein levels of APP and Aβ, with the concomitant APP translocalization, LE-lyso fusion and the improved cognitive functions. Taken together, these data uncover a LE-lyso fusion mechanism in APP degradation and suggest a novel role for AP2S1 in the pathophysiology of AD.

SHMT2 Mediates Small‐Molecule‐Induced Alleviation of Alzheimer Pathology Via the 5′UTR‐dependent ADAM10 Translation Initiation

“…Using glass microsyringe to collect 0.5 microliters of virus particles for each site and bilaterally inject them into CA1 and DG area of the hippocampus. [ 61 ]…”

Cerebral furin deficiency causes hydrocephalus in mice

“…For immunofluorescent labeling, 20 , 21 brain tissues were dehydrated in gradient sucrose solutions. After antigen recovery, tissues were cryo-sectioned (10-μm thickness) by a freezing microtome (Thermo, USA) and permeabilized for 10 min using 0.4% Triton X-100 and blocked using 10% donkey serum (Solarbio, SL050) at 37 °C for 30 min to eliminate nonspecific staining.…”

American Ginseng for the Treatment of Alzheimer’s Disease: A Review

“…The potential therapeutic efficacy of pseudoginsenoside F11 lies in its ability to enhance lysosomal function and facilitate endosome maturation, thereby promoting the elimination of Aβ [136]. Therefore, we hypothesized that the related adapter-associated protein complex 2 subunit sigma 1 (AP2S1) could serve as a potential therapeutic target [224].…”